Navigation Links
Global Trends in the Medical Devices Industry
Date:2/21/2013

LONDON, Feb. 21, 2013 /PRNewswire/ -- Top representatives from the healthcare industry are confirmed to attend MEDTEC Europe, which will take place in Stuttgart, Germany on the 26-28 February 2013. Siddharth Saha , Frost & Sullivan Healthcare Research Director, is set to participate to the event with a presentation focusing on global market trends, challenges and opportunities in the medical devices industry.

Recessionary forces and market maturity notwithstanding, the global medical devices industry is poised for significant growth, driven by emerging markets and solutions that are more aligned to the healthcare ecosystem. Frost & Sullivan will cover trends and opportunities in the global markets looking at metrics, predictions for the future and summary of attractive market segments.

"To stay competitive in the continually shifting market landscape, companies are increasingly looking at re-aligning their value propositions to match with the realities on the ground in high growth markets while also re-setting their internal goals with customer as the focus," said Siddharth Saha , Director of Healthcare Research at Frost & Sullivan.

MEDTEC Europe 2013, which is organised by UBM Canon, will bring together top medical devices representatives under one roof, who will address the industry key issues - ranging from the evolving regulatory landscape to challenges in clinical development, and more. The event will take place in Stuttgart, Germany, on the 26-28 February.

For more information, please click on the following link or contact emily.dobson@ubm.com - www.medteceurope.com

About UBM
UBM is a global live media and B2B communications, marketing service and data
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry
2. Global Pharmaceutical Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry
3. Boston Scientific to Participate in the Citi 2013 Global Healthcare Conference
4. PAREXEL International To Present At Citi Global Healthcare Conference
5. Global Radiopharmaceuticals Market Is Expected to Reach USD 12.2 Billion in 2018: Transparency Market Research
6. UBM Canon, the Global Authority on the MedTech Industry, Announces Senior Editor for MD+DI (Medical Device & Diagnostic Industry)
7. Boehringer Ingelheim Selects ChemAxon to Power Next-Generation Global Cheminformatics Platform
8. Hill-Rom to Participate in the 2013 Citi Global Healthcare Conference
9. Radiation Detection, Monitoring & Safety Market (Geiger Counter, Ionization Chamber, Scintillator, Terahertz detector, Dosimeter, Environment Monitor, Shield, Lead Apron, Eyewear & Glove) - Competitive Analysis & Global Forecasts to 2017
10. Global Lung Cancer Therapeutics Market 2012-2016
11. Perrigo Company To Present At The Leerink Swann Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015 Array BioPharma,s (NASDAQ: ... this past weekend at the 2015 ESMO World ... At the meeting, data were shared from a ... 100-patient randomized Phase 2 expansion of that trial ... EGFR inhibitor, with or without the addition of ...
(Date:7/6/2015)...  Impax Laboratories, Inc. (NASDAQ: IPXL ) today ... from the Company,s Board of Directors in order to ... of Impax in 1995 and served as the Company,s ... April 2014. Logo - http://photos.prnewswire.com/prnh/20150310/180590LOGO ... Chief Executive Officer stated, "We wish to thank Larry ...
(Date:7/6/2015)... SOUTH SAN FRANCISCO, Calif. , July 6, 2015 ... leading global pharmaceutical company, and Oculeve, a development-stage medical ... eye disease, today announced that they have entered into ... an all-cash transaction.  Under the terms of the agreement, ... payment and commercialization milestone payments related to Oculeve,s lead ...
Breaking Medicine Technology:Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 2Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 3Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 4Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 5Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4
... Calif., Sept. 27 Valeant Pharmaceuticals International (NYSE: ... its outstanding 7.625% Senior Notes due 2020 (the "7.625% Notes") ... (together with the 7.625% Notes, the "Notes") on October 27, ... the Notes on September 27, 2010. On and ...
... Sept. 27 Pfizer Inc. (NYSE: ... development pipeline, which includes 118 programs from Phase ... reflect Pfizer,s ongoing investment in high-priority disease areas ... (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO) ...
Cached Medicine Technology:Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016 2Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016 3Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016 4Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need 2
(Date:7/6/2015)... ... July 06, 2015 , ... Acara Partners, a leading business ... of its complimentary educational webinar series for the summer of 2015. ... for their clients through targeted marketing, sales, digital communications, branding and business development ...
(Date:7/6/2015)... ... July 06, 2015 , ... Olive Fertility Centre is proud to announce that ... Award on behalf of the department of Family Practice. , “This award is a ... practicing in. The technology is changing so rapidly and we are also developing new ...
(Date:7/6/2015)... ... July 06, 2015 , ... Cancer Hope Network ... caregivers and medical professionals to chat with the CHN patient services team and ... a cancer diagnosis is often the most traumatic experience of a person’s life,” ...
(Date:7/6/2015)... , ... July 06, 2015 , ... MD Now, the ... July 6. The newly constructed urgent care center will serve residents and visitors in ... addition to being MD Now’s 22nd South Florida location, the new facility will be ...
(Date:7/6/2015)... ... ... World renowned Los Angeles facial plastic surgeon , Dr. Paul Nassif, ... solutions. Individuals that want to make multiple changes to their facial appearance are able ... of their needs. , "Anytime I see an opportunity to change the life ...
Breaking Medicine News(10 mins):Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2
... significant bone mass in the first year after the transplant, ... bodies from rejecting the new organ. The bone loss greatly ... fractures among this group ranges from 22 percent to 44 ... but which drugs work best in this situation is unclear. ...
... suggest that kids who struggle to breathe during sleep ... out. ,Adenotonsillectomy is a common surgical procedure in ... performed to treat recurring bouts of tonsillitis. During the ... to treat obstructive sleep apnea (OSA), a condition in ...
... 34 years old. Advances in chemotherapy and radiotherapy have ... cancer, but since men who get the disease are ... and its treatment on fertility remains. ,While ... found fertility rates unchanged. These conflicting results suggested the ...
... has shown that a chemotherapy regimen combining vinorelbine (Navelbine) ... in the treatment of hormone-refractory prostate cancer . Specialists ... earlier in their disease. , However researchers ... treatment regimen is planned. From a group of 66 ...
... failure is a chronic but deadly condition caused by the ... weaker and weaker. An estimated 5 million Americans ... five years. It can be caused by high blood pressure, ... In a recent study it was seen that heart failure ...
... Previous studies show conflicting results over whether hormone replacement ... A recent study examines the pros and cons of ... combined HRT therapy for five years. All the women ... had menopausal symptoms, while others did not.Results show women ...
Cached Medicine News:Health News:A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer 2
... BX620S. Digital stability control, analog display ... counting and percent measure functions, auto ... and time data from built-in clock. ... (selectable from 200g to 600g). Built-in ...
The EK-H Series offer 10 selectable units of measure...
60 month warranty, constructed entirely of aluminum alloy, allows the selection of 11 units of measure....
The EK-H Series offer 10 selectable units of measure...
Medicine Products: